Archives
Autosomal Dominant Polycystic Kidney Disease (ADPKD): Screening & Diagnosis
About This Event
Autosomal Dominant Polycystic Kidney Disease (ADPKD): Screening & Diagnosis
This presentation discusses the key screening tools and diagnostic algorithms associated with autosomal dominant polycystic kidney disease (ADPKD), including risk assessment tools to assess for rapid progression.
Perry’s Steakhouse & Grille – River Oaks
Biruh T Workeneh, MD, FASN
The University of Texas MD Anderson Cancer Center*
Dr Biruh Workeneh is a provider in the MD Anderson Internal Medicine Center and an Associate Professor in the Section of Nephrology. He is board-certified in Internal Medicine and joined MD Anderson in 2015.
Molly Jansen, PhD
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Dr Molly Jansen is a Nephrology Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. covering South Texas. Molly earned her Doctor of Philosophy degree in Biomedical Science from Wake Forest School of Medicine located in Winston-Salem, NC. While in graduate school, Molly worked as a Business Development Intern at Wake Forest Innovations, fostering the collaborative innovation between industry and the faculty and staff of Wake Forest Baptist Medical Center. After graduate school, Molly did a brief Medical Writing Fellowship with Impact Pharmaceutical Services. Prior to joining Otsuka, Molly worked at Reata Pharmaceuticals, Inc. where she helped to oversee the conduct of clinical trials across a variety of therapeutic areas including nephrology, neurology, and pulmonary, which is where she developed her passion for rare disease.
*Dr Workeneh is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Jansen is an employee of OPDC.
